Pharmaceuticals, Biotechnology and Life Sciences
TrialWire™ is the risk-share pay-per-enrolled AI and algorithm-powered patient recruitment Platform built on Salesforce Health Cloud for industry-leading patient data…
Cash runway into Q3 2026AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout…
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated…
REDWOOD CITY, Calif., May 20, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics…
Oslo, 20 May 2025. PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) issue this notification on behalf of Hans…
Company now exclusively focused on the growing fertility market following the April 2025 announcement to divest a majority stake in…
There are nearly 40,000 U.S. cases of cutaneous squamous cell carcinoma each year that advance to stages that are difficult…
Pharmacokinetic and safety data from healthy volunteers anticipated around YE 2025 On track to initiate a Phase 2 study in…
Topline results for AP02 (inhaled nintedanib) confirmed safety and tolerability with limited systemic exposure and substantially improved lung exposure compared…
Columvi is the first bispecific antibody to show a statistically significant and clinically meaningful 41% survival benefit in R/R DLBCL…